OBJECTIVES: This study assessed trends in HIV risk behaviors among injection drug users in New York City from 1990 to 1997. METHODS: Injection drug users were recruited continuously from a large drug detoxification treatment program (N = 2588) and a research storefront located in a high-drug-use area (N = 2701). Informed consent was obtained, and a trained interviewer administered a structured interview covering sociodemographics, drug use history, HIV risk behavior, and participation in syringe exchange. RESULTS: Trends were assessed for 5 risk behaviors in the 6-month period before the interview. The 3 injection risk behaviors declined significantly over time at each site (all P < .01). When data were pooled across sites, all 5 risk behaviors declined significantly over time (all P < .01). Participation in syringe exchange programs and in HIV counseling and testing increased greatly from 1990 to 1997. CONCLUSIONS: The continuing risk reduction among injection drug users indicates a "declining phase" in the large HIV epidemic in New York City. HIV prevention programs appear to be making an important contribution to the declining phase.
OBJECTIVES: This study assessed trends in HIV risk behaviors among injection drug users in New York City from 1990 to 1997. METHODS: Injection drug users were recruited continuously from a large drug detoxification treatment program (N = 2588) and a research storefront located in a high-drug-use area (N = 2701). Informed consent was obtained, and a trained interviewer administered a structured interview covering sociodemographics, drug use history, HIV risk behavior, and participation in syringe exchange. RESULTS: Trends were assessed for 5 risk behaviors in the 6-month period before the interview. The 3 injection risk behaviors declined significantly over time at each site (all P < .01). When data were pooled across sites, all 5 risk behaviors declined significantly over time (all P < .01). Participation in syringe exchange programs and in HIV counseling and testing increased greatly from 1990 to 1997. CONCLUSIONS: The continuing risk reduction among injection drug users indicates a "declining phase" in the large HIV epidemic in New York City. HIV prevention programs appear to be making an important contribution to the declining phase.
Authors: D C Des Jarlais; M Marmor; P Friedmann; S Titus; E Aviles; S Deren; L Torian; D Glebatis; C Murrill; E Monterroso; S R Friedman Journal: Am J Public Health Date: 2000-03 Impact factor: 9.308
Authors: A H Kilian; S Gregson; B Ndyanabangi; K Walusaga; W Kipp; G Sahlmüller; G P Garnett; G Asiimwe-Okiror; G Kabagambe; P Weis; F von Sonnenburg Journal: AIDS Date: 1999-02-25 Impact factor: 4.177
Authors: D C Des Jarlais; S R Friedman; D M Novick; J L Sotheran; P Thomas; S R Yancovitz; D Mildvan; J Weber; M J Kreek; R Maslansky Journal: JAMA Date: 1989-02-17 Impact factor: 56.272
Authors: K E Nelson; D D Celentano; S Eiumtrakol; D R Hoover; C Beyrer; S Suprasert; S Kuntolbutra; C Khamboonruang Journal: N Engl J Med Date: 1996-08-01 Impact factor: 91.245
Authors: D C Des Jarlais; K Choopanya; S Vanichseni; K Plangsringarm; W Sonchai; M Carballo; P Friedmann; S R Friedman Journal: Am J Public Health Date: 1994-03 Impact factor: 9.308
Authors: D C Des Jarlais; S R Friedman; J L Sotheran; J Wenston; M Marmor; S R Yancovitz; B Frank; S Beatrice; D Mildvan Journal: JAMA Date: 1994-01-12 Impact factor: 56.272
Authors: Don C Des Jarlais; Theresa Perlis; Kamyar Arasteh; Lucia V Torian; Sara Beatrice; Judith Milliken; Donna Mildvan; Stanley Yancovitz; Samuel R Friedman Journal: Am J Public Health Date: 2005-06-28 Impact factor: 9.308
Authors: Abu S Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Keith Sabin; Kathleen Gallagher; Don C Des Jarlais Journal: J Urban Health Date: 2006-05 Impact factor: 3.671
Authors: Shruti H Mehta; Jacqueline Astemborski; Gregory D Kirk; Steffanie A Strathdee; Kenrad E Nelson; David Vlahov; David L Thomas Journal: J Infect Dis Date: 2011-01-31 Impact factor: 5.226
Authors: Hannah Cooper; Don Des Jarlais; Zev Ross; Barbara Tempalski; Brian H Bossak; Samuel R Friedman Journal: J Urban Health Date: 2012-08 Impact factor: 3.671
Authors: Scott S Santibanez; Richard S Garfein; Andrea Swartzendruber; David W Purcell; Lynn A Paxton; Alan E Greenberg Journal: J Urban Health Date: 2006-01 Impact factor: 3.671
Authors: Sabriya L Linton; Hannah L F Cooper; Mary E Kelley; Conny C Karnes; Zev Ross; Mary E Wolfe; Yen-Tyng Chen; Samuel R Friedman; Don Des Jarlais; Salaam Semaan; Barbara Tempalski; Catlainn Sionean; Elizabeth DiNenno; Cyprian Wejnert; Gabriela Paz-Bailey Journal: Ann Epidemiol Date: 2016-08-08 Impact factor: 3.797
Authors: Carol Strike; Daniel Z Buchman; Russell C Callaghan; Cass Wender; Susan Anstice; Brian Lester; Nick Scrivo; Janine Luce; Margaret Millson Journal: Harm Reduct J Date: 2010-02-09